Michael S. Cuffe
CIK 1632835 · EVP and Chief Clinical Officer · last filed 2026-02-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.78M
Companies
1
Total Filings
70
Lifetime Open-Market Net
-$31.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HCA | EVP and Chief Clinical Officer | 35,580 | $387.18 | $13.78M | -$31.92M | 70 | 2026-02-12 |
Recent Filings · Page 3 of 7
70 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-22 | HCA | Mixed | +8,603 | -$974.8K | EDGAR |
| 2021-02-05 | HCA | Mixed | −7,574 | -$5.01M | EDGAR |
| 2020-02-21 | HCA | Mixed | +6,878 | -$428.8K | EDGAR |
| 2020-02-07 | HCA | Sell (S) | −6,459 | -$968.9K | EDGAR |
| 2020-01-31 | HCA | Grant (A) | — | $0 | EDGAR |
| 2019-12-23 | HCA | Mixed | +6,459 | -$2.04M | EDGAR |
| 2019-02-27 | HCA | Mixed | +916 | -$43.3K | EDGAR |
| 2019-02-25 | HCA | Mixed | +6,658 | -$372.1K | EDGAR |
| 2019-02-01 | HCA | Grant (A) | — | $0 | EDGAR |
| 2018-11-09 | HCA | Mixed | — | -$1.16M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.